Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Lead × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Brain Neoplasms 3 Neoplasms 2 Thrombophilia 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Periodontitis 1 Neoplasms, Plasma Cell 1 Motor Activity 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Febrile Neutropenia 1 EGFR-Mutant Lung Cancer 1 Deglutition Disorders 1 Communication Disorders 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Blood Coagulation Disorders 1

Interventions

Sorafenib 38 Oxaliplatin 21 Bevacizumab 21 Radiosurgery 15 Fluorouracil 15 Gemcitabine 14 Nivolumab 11 Hepatectomy 11 Cisplatin 11 lenvatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Leucovorin 9 Doxorubicin 9 durvalumab 8 Liver Transplantation 8 Blood Specimen Collection 8 atezolizumab 7 Capecitabine 7 pembrolizumab 6 camrelizumab 6 Immunohistochemistry 6 Everolimus 6 Electroporation 6 Cyclophosphamide 6 Cryosurgery 6 tremelimumab 5 sintilimab 5 apatinib 5 Sunitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05931068 2024-08-05

PRO-NRG

Academisch Ziekenhuis Maastricht

Gastrointestinal

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡